相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complex Deregulation and Expression of Cytokines and Mediators of the Immune Response in Parkinson's Disease Brain is Region Dependent
Paula Garcia-Esparcia et al.
BRAIN PATHOLOGY (2014)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease
Natalia Pessoa Rocha et al.
MOVEMENT DISORDERS (2014)
The Prevalence of Parkinson's Disease: A Systematic Review and Meta-analysis
Tamara Pringsheim et al.
MOVEMENT DISORDERS (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
THE INTERNATIONAL INCIDENCE AND PREVALENCE OF NEUROLOGIC CONDITIONS: HOW COMMON ARE THEY?
Tamara Pringsheim et al.
NEUROLOGY (2014)
Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Joao P. L. Daher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease
Natalia Pessoa Rocha et al.
PARKINSONS DISEASE (2014)
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment
Daniel Lindqvist et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
Erwan Bezard et al.
MOVEMENT DISORDERS (2013)
Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia
Paul Edison et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus
Daniah Trabzuni et al.
PLOS ONE (2013)
Animal models of neurodegenerative diseases
Fabiola Mara Ribeiro et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2013)
Inflammatory cytokines and NT-proCNP in Parkinson's disease patients
Dariusz Koziorowski et al.
CYTOKINE (2012)
Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease
Fumitoshi Niwa et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2012)
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease
Tiziana Alberio et al.
IUBMB LIFE (2012)
CD4+Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson's Disease
Jessica A. Hutter Saunders et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Reduced T helper and B lymphocytes in Parkinson's disease
Claire H. Stevens et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Neuropathology of Sporadic Parkinson's Disease: Evaluation and Changes of Concepts
Kurt A. Jellinger
MOVEMENT DISORDERS (2012)
Association of Parkinson's disease with infections and occupational exposure to possible vectors
M. Anne Harris et al.
MOVEMENT DISORDERS (2012)
Toward a Redefinition of Parkinson's Disease
Matthew B. Stern et al.
MOVEMENT DISORDERS (2012)
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Louise M. Collins et al.
NEUROPHARMACOLOGY (2012)
Genomic determinants of motor and cognitive outcomes in Parkinson's disease
Sun Ju Chung et al.
PARKINSONISM & RELATED DISORDERS (2012)
Non-Motor Symptoms in Patients with Parkinson's Disease - Correlations with Inflammatory Cytokines in Serum
Daniel Lindqvist et al.
PLOS ONE (2012)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor
Alessandra Nicoletti et al.
CYTOKINE (2011)
Genome-wide association study confirms extant PD risk loci among the Dutch
Javier Simon-Sanchez et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
NSAID use and risk of Parkinson disease: a population-based case-control study
C. Becker et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Parkinson's Disease
Angelika D. Manthripragada et al.
NEUROEPIDEMIOLOGY (2011)
Serum Levels of Chemokines in Parkinson's Disease
Paula Scalzo et al.
NEUROIMMUNOMODULATION (2011)
Use of ibuprofen and risk of Parkinson disease
Xiang Gao et al.
NEUROLOGY (2011)
BCG Vaccine-Induced Neuroprotection in a Mouse Model of Parkinson's Disease
Jing Yong et al.
PLOS ONE (2011)
α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
Kiran Yanamandra et al.
PLOS ONE (2011)
Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation
Jonathan Thevenet et al.
PLOS ONE (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study
Jane A. Driver et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Parkinsonism in patients with chronic hepatitis C treated with interferon-α2b: a report of two cases
Mikio Kajihara et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
Francesca L'Episcopo et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Apoptosis of peripheral blood lymphocytes in Parkinson patients
Matil Calopa et al.
NEUROBIOLOGY OF DISEASE (2010)
Chronic expression of low levels of tumor necrosis factor-α in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation
Ana Laura De Lella Ezcurra et al.
NEUROBIOLOGY OF DISEASE (2010)
Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
Joshua J. Gagne et al.
NEUROLOGY (2010)
Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance
Paula Scalzo et al.
NEUROSCIENCE LETTERS (2010)
[C-11]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
A. L. Bartels et al.
PARKINSONISM & RELATED DISORDERS (2010)
Circulating interleukin-10 and interleukin-12 in Parkinson's disease
M. Rentzos et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Peripheral cytokines profile in Parkinson's disease
M. Reale et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Radiolabelled Molecules for Imaging the Translocator Protein (18 kDa) Using Positron Emission Tomography
Frederic Dolle et al.
CURRENT MEDICINAL CHEMISTRY (2009)
NSAID Use and the Risk of Parkinson's Disease Systematic Review and Meta-Analysis of Observational Studies
Ali Samii et al.
DRUGS & AGING (2009)
Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease
Paula Scalzo et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Interleukin-6 Serum Levels in Patients with Parkinson's Disease
Kerly Wollmeister Hofmann et al.
NEUROCHEMICAL RESEARCH (2009)
CXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson's Disease
Mika Shimoji et al.
NEUROTOXICITY RESEARCH (2009)
Increased oxidative stress in lymphocytes from untreated Parkinson's disease patients
Alessandro Prigione et al.
PARKINSONISM & RELATED DISORDERS (2009)
Serum inflammatory biomarkers in Parkinson's disease
M. Dufek et al.
PARKINSONISM & RELATED DISORDERS (2009)
Neuroinflammation in the living brain of Parkinson's disease
Yasuomi Ouchi et al.
PARKINSONISM & RELATED DISORDERS (2009)
Rheumatoid arthritis accompanied by Parkinson disease
Toshiaki Kogure et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study
Mahyar Etminan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk
Karen M. Powers et al.
MOVEMENT DISORDERS (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
Natural killer cells of Parkinson's disease patients are set up for activation: A possible role for innate immunity in the pathogenesis of this disease
Tomoko Mihara et al.
PARKINSONISM & RELATED DISORDERS (2008)
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Hui-Ming Gao et al.
TRENDS IN IMMUNOLOGY (2008)
Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Peripheral inflammatory biomarkers and risk of Parkinson's disease
Honglei Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Angelika D. Wahner et al.
NEUROLOGY (2007)
Rheumatoid-like hand deformities in Parkinson disease
Meltem Alkan Melikoglu et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2007)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
Marjolijn Bornebroek et al.
NEUROEPIDEMIOLOGY (2007)
Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease
Dana B. Hancock et al.
ARCHIVES OF NEUROLOGY (2007)
Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease
Angelika D. Wahner et al.
ARCHIVES OF NEUROLOGY (2007)
Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra
Carina Cintia Ferrari et al.
NEUROBIOLOGY OF DISEASE (2006)
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease
Melissa K. McCoy et al.
JOURNAL OF NEUROSCIENCE (2006)
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease
Thanh G. Ton et al.
MOVEMENT DISORDERS (2006)
Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis
Alessia Bachis et al.
JOURNAL OF NEUROSCIENCE (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
HL Chen et al.
ANNALS OF NEUROLOGY (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease
A Håkansson et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Microglial activation and dopamine terminal loss in early Parkinson's disease
Y Ouchi et al.
ANNALS OF NEUROLOGY (2005)
Alterations of T-lymphocyte populations in Parkinson disease
Y Baba et al.
PARKINSONISM & RELATED DISORDERS (2005)
Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection
N Atasoy et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
S Gangemi et al.
MEDIATORS OF INFLAMMATION (2003)
Juvenile parkinsonism as a manifestation of systemic lupus erythematosus:: Case report and review of the literature
JM García-Moreno et al.
MOVEMENT DISORDERS (2002)
Association of interieukin-1β polymorphisms with idiopathic Parkinson's disease
PL McGeer et al.
NEUROSCIENCE LETTERS (2002)
Amantadine in Parkinson's disease:: lymphocyte subsets and IL-2 secreting T cell precursor frequencies
GG Tribl et al.
EXPERIMENTAL GERONTOLOGY (2001)
Neuropsychiatric effects and type of IFN-α in chronic hepatitis C
M Malaguarnera et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
J Bas et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and-2
C Knott et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2000)
The peripheral benzodiazepine binding site in the brain in multiple sclerosis -: Quantitative in vivo imaging of microglia as a measure of disease activity
RB Banati et al.
BRAIN (2000)
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro
D Casper et al.
NEUROSCIENCE LETTERS (2000)
Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain
M Mogi et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease
R Kruger et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
